180 related articles for article (PubMed ID: 2524668)
1. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Bernstein DC; Mann DL; Shearer GM; Berzofsky JA
Nature; 1989 Jun; 339(6223):383-5. PubMed ID: 2524668
[TBL] [Abstract][Full Text] [Related]
2. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
[TBL] [Abstract][Full Text] [Related]
3. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
Clerici M; Tacket CO; Via CS; Lucey DR; Muluk SC; Zajac RA; Boswell RN; Berzofsky JA; Shearer GM
Eur J Immunol; 1991 Jun; 21(6):1345-9. PubMed ID: 1845391
[TBL] [Abstract][Full Text] [Related]
4. Immunologic abnormalities related to antigenaemia during HIV-1 infection.
De Paoli P; Battistin S; Crovatto M; Modolo ML; Carbone A; Tirelli U; Santini G
Clin Exp Immunol; 1988 Dec; 74(3):317-20. PubMed ID: 2976619
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
Clerici M; Wynn TA; Berzofsky JA; Blatt SP; Hendrix CW; Sher A; Coffman RL; Shearer GM
J Clin Invest; 1994 Feb; 93(2):768-75. PubMed ID: 8113410
[TBL] [Abstract][Full Text] [Related]
6. Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection.
Clerici M; Via CS; Lucey DR; Roilides E; Pizzo PA; Shearer GM
Eur J Immunol; 1991 Mar; 21(3):665-70. PubMed ID: 1672645
[TBL] [Abstract][Full Text] [Related]
7. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
8. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
[TBL] [Abstract][Full Text] [Related]
9. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
Miedema F; Petit AJ; Terpstra FG; Schattenkerk JK; de Wolf F; Al BJ; Roos M; Lange JM; Danner SA; Goudsmit J
J Clin Invest; 1988 Dec; 82(6):1908-14. PubMed ID: 2974045
[TBL] [Abstract][Full Text] [Related]
10. Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals.
Schulick RD; Clerici M; Dolan MJ; Shearer GM
Eur J Immunol; 1993 Feb; 23(2):412-7. PubMed ID: 8436177
[TBL] [Abstract][Full Text] [Related]
11. Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Via CS; Shearer GM
J Immunol; 1990 May; 144(9):3266-71. PubMed ID: 1970348
[TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.
Lusso P; Markham PD; Ranki A; Earl P; Moss B; Dorner F; Gallo RC; Krohn KJ
J Immunol; 1988 Oct; 141(7):2467-73. PubMed ID: 3262661
[TBL] [Abstract][Full Text] [Related]
13. A Th0/Th2-like function of CD4+CD7- T helper cells from normal donors and HIV-infected patients.
Autran B; Legac E; Blanc C; Debré P
J Immunol; 1995 Feb; 154(3):1408-17. PubMed ID: 7529803
[TBL] [Abstract][Full Text] [Related]
14. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
15. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.
Clerici M; Hakim FT; Venzon DJ; Blatt S; Hendrix CW; Wynn TA; Shearer GM
J Clin Invest; 1993 Mar; 91(3):759-65. PubMed ID: 8450057
[TBL] [Abstract][Full Text] [Related]
16. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings.
Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC
J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967
[TBL] [Abstract][Full Text] [Related]
17. Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.
Girolomoni G; Valle MT; Zacchi V; Costa MG; Giannetti A; Manca F
Immunology; 1996 Feb; 87(2):310-6. PubMed ID: 8698396
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.
Krowka J; Stites D; Debs R; Larsen C; Fedor J; Brunette E; Düzgünes N
J Immunol; 1990 Apr; 144(7):2535-40. PubMed ID: 1969450
[TBL] [Abstract][Full Text] [Related]
20. Amplification of T-cell blastogenic responses in healthy individuals and patients with acquired immunodeficiency syndrome.
Dis Markers; 1990; 8(4):223-4. PubMed ID: 2150930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
